MyFinsight
Home
Blog
About
Contact
Download
Download image
Comprehensive loss
-$10,118K
Net loss
-$10,042K
Unrealized loss on
marketable securities
-$76K
Loss before income
tax expense
-$10,035K
Income tax expense
$7K
Other income, net
$447K
Operating loss
-$10,482K
Research and development
$7,987K
General and
administrative
$2,495K
Back
Back
Income Statement
source: myfinsight.com
DiaMedica Therapeutics Inc. (DMAC)
DiaMedica Therapeutics Inc. (DMAC)